Promis Neurosciences Inc (PMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,574 | -7,844 | -4,644 | -2,609 | N/A |
| Depreciation Amortization | 7 | 5 | 5 | 5 | N/A |
| Accounts receivable | -15 | -7 | 0 | -7 | N/A |
| Other Working Capital | 490 | 341 | -287 | 250 | N/A |
| Other Operating Activity | 503 | 836 | 529 | 441 | 0 |
| Operating Cash Flow | $-4,589 | $-6,669 | $-4,397 | $-1,921 | $N/A |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $0 | $0 | $0 | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -87 | N/A | N/A |
| Common Stock Issued | 4,515 | 6,724 | 5,238 | 1,777 | N/A |
| Other Financing Activity | -474 | 485 | 0 | 0 | 0 |
| Financing Cash Flow | $4,041 | $7,209 | $5,151 | $1,777 | $N/A |
| Beginning Cash Position | 1,801 | 1,304 | 549 | 682 | N/A |
| End Cash Position | 1,252 | 1,844 | 1,304 | 538 | N/A |
| Net Cash Flow | $-549 | $540 | $754 | $-144 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,589 | -6,669 | -4,397 | -1,921 | N/A |
| Free Cash Flow | -4,589 | -6,669 | -4,397 | -1,921 | 0 |